Reason for request
Extension of indication
Clinical Benefit
| Substantial |
Substantial in type 1 diabetes in children aged 2 to 5 years. |
Clinical Added Value
| no clinical added value |
LANTUS provides no improvement in actual benefit (IAB V, non-existent) in the management of children aged 2 to 5 years with type 1 diabetes. |
eNq1mF1v2jAUhu/5FVHuSfgotEyBamPthtSqjBZt2k1lkgOYpXZ6bPOxXz+HUI1Ojro6+DK2854Tn9ePjxJdbp9Sbw0oKGd9vxk0fA9YzBPKFn1/+nBdv/AvB7VoRdbkaNl50AiaLd+LUyJE389ngxkQJoIftzefQb8P6A9qXsRnK4jlq3VK0jT4SsTylmT5Gi9ac5p4TyCXPOn7mZL7US8SEnUWgw3HXyIjMUThYeR4dvV4djwehbnYf6gqAXhD2MIoCsxKM1aIwOSQSFhw3JXk27bSpmICgiuMYUzkcox8TRNIjCHmJBVgFWS+Se4B1ynIPIhRPFzFT8JKnKzIdgLPI3PSH/XsUG5lvVFvnne67e5Zt9Fq97pWofBoq8xV0B8Rxo/N81ar17AtyJijJKmjUlAxfO0mR3EQnt8seUJFlpJdsBKZ7VYRJHoaUJ95dx+Sf8EDagqles/+0WcqTcN3Zj09MMJRxjmChlwxWYKK64ntRgw5k7Atr6gd3eT24EUK4nSyvzkzk32sZimNbTmmSaNAyOlkVI6xygT4RARM0R0CvlOW8I04PVqOS+ko+2xPR6NohknzsdW76DY7HeuT81P7puQuuVLIMwg1dKiowpIRm/OqFNFWNEu9GLGaB/dtDI9JCiWNTN2SItp8L32XM3u7OzrFhFH0y9WDrSe+KcDd/f7RKE2TfrVqxi64rR1Ymvj7/VwcayctrkIzLpZSZuJDGG42m2BJRF0QvUvBHE/D8KO70l1X7eRCLhqUgoOOUp8VF9z7ymJ7vN66squ2oYf3D+2uMYZEBRVqUZDYGS9HV6dH8N8e1Fna41fIcBdm3y8SSTlz1dKomVGxKoJG7Bo1IO7mc1ryl6PUl1FY/GEZ1KIw/7syqP0B2LrUHA==
mcJQYUVBr5XV55FV
Listen
